Intensive pharmacovigilance of high-risk patients on hospital surgical wards.
- Conditions
- High risk patients on (orthopaedic) surgical wards
- Registration Number
- NL-OMON24911
- Lead Sponsor
- Canisius Wilhelmina Hospital/Department Clinical PharmacyRadboud University Nijmegen Medical CenterMevr. J.M. Bos, hospital pharmacistDr. C. Kramers, internist-clinical pharmacologist
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 10600
Inclusion Criteria
All patients admitted to wards of surgery and orthopaedic surgery of two hospitals during the study period, consisting of 6 months usual care and 6 months intervention (sample size per group is 5300).
Exclusion Criteria
N/A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method nintended drug related problems due to prescription errors, that lead to death, disability, increased length of hospital stay and readmission.<br /><br>Outcomes are judged by opinions of a panel of experts.
- Secondary Outcome Measures
Name Time Method 1. Serious prescription errors;<br /><br>2. Non-serious prescription errors;<br /><br>3. Guideline adherence.<br /><br>Outcomes are judged by opionions of a panel of experts.<br /><br>A pharmaco-economic evaluation will be performed.